CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 700 enrolled
Drug / intervention
procalcitoninother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04158804
NCT04158804N/ACompleted

PROcalcitonin Impact on Antibiotic Reduction, adverSe Events and AVoidable healthcarE Costs

Massachusetts General Hospital·interventional·Posted Nov 12, 2019·Updated Mar 20, 2025

In Brief

A clinical study evaluating procalcitonin for Pneumonia, Bacterial. Completed, enrolled 700 participants across 6 sites.

Detailed Summary

Trials comparing PCT-guided antibiotic algorithms to standard management show a significant reduction in antibiotic exposure without an increase in mortality or treatment failure. Despite this strong evidence from multiple studies a recent prospective multicentric interventional trial in the US fell short of demonstrating antibiotic reductions by PCT-guided antibiotic management. Amongst other limitations the authors of that study concluded that successful implementation of PCT may require closer educational oversight. As such, this study will compare effectiveness and safety of antibiotic prescription guided by a PCT-algorithm via a Stewardship Team over standard guidelines in hospitalized adult patients with suspected or confirmed LRTI (including sepsis with respiratory focus).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedNov 12, 2019
Enrollment StartMay 28, 2020
Primary CompletionJun 17, 2023
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 6.6 years ago

Interventions

procalcitoninother

accuracy of procalcitonin as a diagnostic marker in guiding antibiotic therapy in patients with a lower respiratory tract infection